Cart
sales@molnova.com
BHQ
CAS No. 88-58-4
BHQ( —— )
Catalog No. M20884 CAS No. 88-58-4
BHQ is an effective and selective endoplasmic reticulum Ca2+-ATPase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | 37 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBHQ
-
NoteResearch use only, not for human use.
-
Brief DescriptionBHQ is an effective and selective endoplasmic reticulum Ca2+-ATPase inhibitor.
-
DescriptionBHQ is an effective and selective endoplasmic reticulum Ca2+-ATPase inhibitor.
-
In VitroDTBHQ influences arachidonic acid (AA) metabolism in biologically relevant concentrations in vitro.
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetATPase
-
RecptorCa2+-ATPase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number88-58-4
-
Formula Weight222.32
-
Molecular FormulaC14H22O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:10mg/mL(44.98mM)
-
SMILESCC(C)(C)c1cc(O)c(C(C)(C)C)cc1O
-
Chemical Name25-Di-tert-butylhydroquinone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Fusi F Saponara S Gagov H et al. 25-Di-t-butyl-14-benzohydroquinone (BHQ) inhibits vascular L-type Ca2+channel?via?superoxide anion generation?[J]. British Journal of Pharmacology 2001 133(7):988-996.
molnova catalog
related products
-
Oligomycin A
Oligomycin A, created by Streptomyces, acts as a mitochondrial F0F1-ATPase inhibitor, with a Ki of 1 μM.
-
Mtb ATP synthase-IN-...
Mtb ATP synthase-IN-1 (compound 6ab) is a potent inhibitor of Mycobacterium tuberculosis (Mtb) ATP synthase (MIC = 0.452-0.499 μg/mL) that can be used in anti-mycobacterium research, showing low cytotoxicity (Vero IC 50 > 64 μg/mL) and acceptable oral bioavailability with good metabolic stability.
-
Thevetin B
Thevetin B is a cardiac glycoside. Thevetin A and thevetin B are Na+-, K+-dependent adenosinetriphosphatase (Na+,K+-ATPase) (EC 3.6.1.3) inhibitors.
